Discovery of clinical candidate methyl (5-(6-((4(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) : A highly potent and selective PI3K alpha inhibitor for the treatment of advanced solid tumors
文献类型：期刊论文
| 作者 | Xiang, Haoyue; Wang, Xiang; Chen, Yanhong; Zhang, Xi; Chen, Yi ; Tan, Cun; Wang, Yi; Ding, Jian; Meng, Ling-Hua; Yang, Chunhao
|
| 刊名 | CANCER RESEARCH
 |
| 出版日期 | 2018-07-01 |
| 卷号 | 78期号:13页码:2 |
| ISSN号 | 0008-5472 |
| DOI | 10.1158/1538-7445.AM2018-LB-268 |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000468818900414 |
| 出版者 | AMER ASSOC CANCER RESEARCH |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/289602]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | Shanghai Inst Mat Med, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Xiang, Haoyue,Wang, Xiang,Chen, Yanhong,et al. Discovery of clinical candidate methyl (5-(6-((4(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) : A highly potent and selective PI3K alpha inhibitor for the treatment of advanced solid tumors[J]. CANCER RESEARCH,2018,78(13):2. |
| APA | Xiang, Haoyue.,Wang, Xiang.,Chen, Yanhong.,Zhang, Xi.,Chen, Yi.,...&Yang, Chunhao.(2018).Discovery of clinical candidate methyl (5-(6-((4(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) : A highly potent and selective PI3K alpha inhibitor for the treatment of advanced solid tumors.CANCER RESEARCH,78(13),2. |
| MLA | Xiang, Haoyue,et al."Discovery of clinical candidate methyl (5-(6-((4(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) : A highly potent and selective PI3K alpha inhibitor for the treatment of advanced solid tumors".CANCER RESEARCH 78.13(2018):2. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。